Science

Feb 13, 2025, 17:00

Myeloma Paper of the Day, February 12th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CAR+ T-cell lymphoma after cilta-cel therapy for relapsed or refractory myeloma that developed in two patients treated on the phase 3 CARTITUDE-4 trial who had evidence of detectable CAR transgene expression and integration.”

“CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma”

Authors: Simon Harrison, Cyrille Touzeau, Nicolas Kint, Benoit Tessoulin, Piers Blombery et al.

More posts featuring Robert Orlowski.

Benoit Tessoulin cancer CAR+ T-cell lymphoma CARTITUDE-4 Cilta-cel Therapy Cyrille Touzeau Myeloma Paper of the Day Nicolas Kint OncoDaily Oncology Piers Blombery refractory myeloma relapsed myeloma Robert Orlowski Simon Harrison

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology

Leo Messi, Richard Gere and Alejandra, Princess Dina and Paco Arango join the Global OncoThon to support childhood cancer research